Vaccination remains the best defense against COVID-19 and pharmacy professionals continue to play a significant role in protecting the health of their patients through the administration of COVID-19 vaccines. To support pharmacy professionals during discussions with patients about Moderna Spikevax Bivalent COVID-19 vaccine, OPA has developed the following collection of Frequently Asked Questions to cover topics such as recommendations for use and eligibility, vaccine preferences, effectiveness and safety, and more!


(Note: This tool was developed with a grant provided by Moderna Biopharma Canada Corporation and does not replace professional judgment and responsibilities.)


Please note, the information in this FAQ is relevant as of October 2022.